Gene expression profiles in the Peyronie's disease plaque

Area of Science:

• Molecular Biology
• Genetics
• Urology

Background:

• Peyronie's disease (PD) is a fibrotic condition affecting the tunica albuginea.
• Understanding the molecular mechanisms underlying PD pathophysiology is crucial for developing effective treatments.

Purpose of the Study:

• To investigate differential gene expression in PD plaques compared to healthy controls.
• To identify molecular pathways involved in PD pathogenesis using DNA microarrays.

Main Methods:

• Gene expression profiling of seven PD plaques and five control tunica albuginea tissues using DNA microarrays (Clontech and Affymetrix).
• Validation of selected gene expression changes using reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blot analysis.

Main Results:

• Upregulation of genes associated with osteoblast recruitment (pleiotrophin), inflammation (monocyte chemotactic protein 1), fibroblast proliferation (early growth response protein), and myofibroblast differentiation (alpha-smooth muscle actin, desmin) in PD plaques.
• Downregulation of genes involved in tissue remodeling (ubiquitin, Id-2) and inhibition of certain processes (collagenase IV, TGF-beta modulators).
• Identification of elastase upregulation, suggesting a role in elastic fiber degradation within PD plaques.

Conclusions:

• PD tissue exhibits altered gene expression profiles, with upregulation of genes promoting collagen synthesis, myofibroblast differentiation, inflammation, and ossification.
• Downregulation of genes that normally inhibit these processes and collagenase activity contributes to PD development.
• These findings provide molecular insights into Peyronie's disease pathophysiology.